1/x The window we have been targeting for 2 months has officially opened... i Can not imagine a more textbook display of the power of Vanna at expiration as we saw on Friday. The capital building was overrun by an insurrection, but all that that meant was a bigger late day rally.

1/x ‘Twas the night before Christmas & all through the market not an order was stirring not even for $TGT.
The bonuses were entered into payroll with care,
In hopes that next year would bring a similar fare;
The Bulls were nestled all snug in their beds;

2/x While visions of $TSLA danced in their heads;
& Biden in his Covid mask, & Powell with his still flowing money tap,
Had just settled their brains for a long winter's nap,
When out on the screen there arose such a clatter,
All sprang from their beds to see what was the matter.

3/x Away to their monitors they flew like a flash,
Tore open their Bloombergs & threw up the dash(board).
The S. Claus rally in markets, that all of us know,
Paired w/vaccine reopening, Gave a bid to the market, leaving old prices below,
When what to their wondering👀 did appear?

4/x But a Georgia runoff rushing up to them with complacency, not fear...
With once reliable Vanna flows no longer lively & quick,
They knew in a moment the markets might get quite sick...
Unexpected, 2 Georgia Dem peaches into Congress they came,

5/x Whistling & shouting they called for more fiscal, ‘CARES Too’ its new name:
"Now, Healthcare! Now, Infrastructure! Now Green Energy & Protectionism!
On, Labor rights! on, Minimum Wage! on, Basic Income & Populism!
To middle class households, To the poorest of them all!

1/ Ch-ch-ch-ch-changes (Turn and face the strange)... as futures, sit pinned @ an odd elevated morning perch awaiting Janet Yellen’s confirmation hearing & her call for the new admin to ‘act big’...this narrative has markets on high. But the truth is that it’s actually just Gary

2/x behind the curtain, pulling the usual levers. Until Vixperation on Wed, it‘ll be nearly impossible to break the IVol oversupply. This pinning of IVol was so strong on Fri that despite a peak to trough drop of nearly -2% in SPX, fixed strike straddle were down across the board

3/x & particularly decimated in the very front of the curve. IVol particularly in the 30 day range is showing dramatic signs of oversupply relative to the rest of the IVol surface, giving a nod to the Vix strip driving the compression. Even during windows of vanna weakness as we

4/x are in now, this oversupply phenomenon paired w/ a market decline & a slide to higher fixed strike IVols can still lead to a temporary ‘Dead Cat Bounce’ where residual Vanna/charm morning flows lead to brief AM market support. These supporting flows are generally just strong

5/x enough for a countertrend thrust &, unable to meaningfully impact more important macro flows & hence generally should be faded starting around 9-10am CST. That said Gary’ll likely see to it that there is no major technical break below 1 stdev in the 20 days, likely preventing

1/x Vanna is back & ready to turn back on the charm! Overnight the market hit our weeklong target of **3705 and pulled back... We were able to take profits & play for a bit of morning digestion. It’s been a nice +3.5% in a week w/a few extra scalps along the way...But the best

2/x part has been the gift of Vol compression, which along w/ short Vol profits, has given us significant calendar expansion & dispersion opps, as predicted. I expect this to continue this week as well, as Ivol oversupply should continue to be the dominant force until 12/11.This,

3/x paired w/ the significantly increasing Vanna & Charm flows, will make it hard for any decline until 12/14 to catch meaningful momentum. This said, the narrowing of 20 day RVol as well as the 2 stddev of the 20 day just overhead should cap any rallies, given the dramatically

4/x overextended retail (8-day SMA of P/C equity is the lowest in 20 years) & institutional positioning. This push/pull, should ultimately keep the market fairly pinned this week...Jan 8th call’s on back are incredibly cheap w/ a GA runoff event straddle of only $55, which given

5/x the potential macro-cyclical consequences of the next 2 years of fiscal stimulus seems absurd...& In terms of a more short term trade,Tesla Vol is either too high or 12/18 on back calendar spreads in the SPX are too low, as there’s no premium being priced in for the inclusion

1/ Vanna’s a widow maker... waging war with her & Gary is exhausting... we were able to take a textbook short at 3803 and take a profit On half at 3771. We will look to add more in a similar way on tomorrow morning’s likely vanna rally again... looking for exuberance once again

2/ in that 9-10am CST window. The growing chorus of bulls emboldened by Vanna’s continued support the last few days gives me confidence that this opportunity will be there again. W/Gary & Vanna behind them the retail exuberance is rising to a fever pitch. This is exactly what we

3/ want to see. But what happens when their backup is gone?? Who’s going to buy this market at these increasingly higher levels this week. Better yet who’s going to buy it @ lower levels when they are forced to sell next week? Not Vanna. She’ll be @ the beach. It ain’t cool bein’

4/ no Jive Turkey so close to Thanksgiving (OpEx)... Bear Steepening of the yield curve took a breather yesterday & so did the stair steps, which was a bit discouraging, no 2 ways about it. But those pressures are far from over. But... remember w/ Vanna still at 1/2 force SPX was

5/ still just unchanged. W/out EOD vanna flows where would the market have been yesterday? The NDX generals continue to be violently shot 1 by 1 as the rotation continues. The last generals will be BTC & TSLA. Watch them closely... listen closely into the rally. The fear of Covid

2018 was almost the year we won the #RightToRepair.

Instead, 2018 turned out to be the year we lost #R2R: 20 bills defeated in 20 state houses, and it was mostly @apple's fault.

1/

Apple has a problem. As CEO Tim Cook warned his investors at the conclusion of his company's repair-killing lobbying spree, Apple's profits depend on people throwing away their devices, not fixing them.

By monopolizing repairs, Apple doesn't just get to gouge you on parts and service - the real action is in pronouncing your device DOA, beyond repair. Then you have to buy another one.

3/

Other companies lobbied hard against R2R: John Deere, GM, and other monopolists backed Apple's play. But Apple wrote the playbook, coming up with risible bullshit like claims that blocking independent repair is essential to protecting

Apple's anti-repair FUD got picked up and amplified by Big Car in 2020, when they spent millions fighting an automotive R2R ballot initiative in Massachusetts, claiming that letting independent mechanics at your car would lead to your actual MURDER.

Piper Alpha was an originally designed as an oil producing rig in the North Sea approximately 120 miles North East of Aberdeen, Scotland. It was a fixed leg platform in water depth of 475 Feet of water. The installation sat close to 275 Feet above water to the top of the derrick.

2) It started production in December 1976 for OPCAL joint venture. OPCAL being Occidental Petroleum Caledonia, Texaco Britain, Thomson PLC, and Texas Petroleum LTD. Occidental was the majority stakeholder at 36.5%

3) Occidental being majority stakeholder took control of technical and operational duties with running and operating the rig. When oil production started in 1976 it started with a flow of 250,000 BBL/day and eventually increasing this amount to 300,000 BBL/day.

4) 300,000 BBL/day would account for approximately 10% of the UK’s oil production at the time, so needless to say it was one of the most important rigs in the area. Any gas that was flowing would be flared or consumed by gas turbine generators

5) Around 1980 there was a decision to convert the rig to also process gas along with the oil. This was a major conversion, and if it would have been scoped in from the beginning, most likely construction of the rig would have been more accommodating for gas.

Thread:
An explosive new criminal complaint against Martin Inacker, the former CEO of @wpmeurocom in #Germany shows Inacker potentially double crossing his #Saudi clients by colluding with #Qatar to cover up Doha's #Hezbullah's sponsorship in exchange for hush money.

According to the complaint, Inacker had kept the terms of his initial agreement with the #Saudi Ministry of Information (following his work with the Saudi Embassy in Berlin) secret from @wmpeurocom 's Board of Directors.

He had used unethical methods to promote a hyperbolized, if not outright mendacious, brochure that was supposed to improve the image of #KSA and the royal family. He had promised a list of high level political and business context to the Saudis as part of his business.

A strategy paper developed by Inacker was leaked to the papers showing unethical, and possibly illegal pressure on ten journalists to switch their "tone" on #KSA as a result of Inacker's lobbying efforts.

However, despite throwing these journalists under the bus, by his own admission Inacker did not appear to have succeeded in pressuring them to "switch their tone". This shows Inacker's duplicity: 1) he lied to his Saudi clients about his alleged success.

1. A company that has been brewing just outside our Top-5 for some time now is the electroporation (EP) company MaxCyte. Modelio assesses it as one of the best investments to capture the growing gene editing and gene therapy space, especially in allogeneic ex-vivo treatments.

2. We estimate that MaxCyte stands before a huge inflection point that will accelerate both growth and profitability. We have seen signs of the accelerating underlying activity by the fact that they in the last two years have added 9 of their 12 commercial agreements.

3. What makes MaxCyte unique compared to other “pick-and-shovel” businesses is their claim to milestones and royalties, something usually reserved for pharmaceutical companies.

4. As per the January update, MaxCyte has a potential pool of $950m in milestones, and a 2-3% (our estimates) of sales in royalties, that excludes licenses and consumables for the machines.

5. Reviewing the partners' pipelines, we think milestone revenues will unleash themselves in 2021 and beyond as they move further into clinical trials.